Over 25 lung cancer therapeutic antibodies are currently in development says new research

Piribo, the online destination for Pharma intelligence, has added a new report.
By: Joe Walsh
 
Oct. 6, 2011 - PRLog -- The report “Lung Cancer Therapeutic Antibodies” available at
http://www.pharmaceutical-market-research.com/publications/diseases_conditions/asthma/asthma_copd_therapies.html provides a complete review of 27 candidate therapeutic antibodies that are being evaluated for the treatment of lung cancer. Globally, lung cancer is the most common cancer and in 2008 there were an estimated 1.6 million new cases and 1.4 million deaths (almost 20% of all cancer deaths) caused by this disease. Five-year survival rates are also low (15-20%) compared to other common cancers.

Patient needs and the high burden of lung cancer on society drive the development of new therapies. While advances have been seen in diagnosis and treatments (surgery, radiotherapy, chemotherapy and targeted drugs), new therapies that build on the capabilities of existing approaches are urgently required.

Today, developments continue to be made in drug treatments for lung cancer; in chemotherapy, new drug combinations, and targeted molecules. More than 25 candidate therapeutic antibodies are in development or are being evaluated for the treatment of lung cancer, most of which are already in clinical trials. This field is also showing substantial innovation and these molecules are being directed at 17 different targets. This report gives an overview of the status and clinical findings of these candidate vaccines, together with developmental and market-related perspectives in this field.

The report “Lung Cancer Therapeutic Antibodies” is available from Piribo at:
http://www.pharmaceutical-market-research.com/publication...

Piribo product ID: BPR00021

About Piribo

Piribo is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books. Piribo has ongoing relationships with leading market research and publishing companies, so we can offer you a current and comprehensive range of specialised intelligence.

# # #

About Piribo.
Piribo http:www.piribo.com is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books.
End
Source:Joe Walsh
Email:***@piribo.com Email Verified
Zip:SE1 3LJ
Tags:Lung, Cancer, Therapeutic
Industry:Medical, Health, Pharmaceutical
Location:London City - London, Greater - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Piribo News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share